Szarkóma: vizsgálatok itt: Kína
106 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaComparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 3300
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07575724 - 1. fázisTaking peopleA Study of DEG6498 in Participants With Solid Tumors
- Where
- Beijing, Guangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Degron Therapeutics Co.
See details and how to joinNCT07244835 - 1. fázisTaking peopleTumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 16
- Run by
- Sun Yat-sen University
See details and how to joinNCT07648069 - 2. fázisTaking peopleToripalimab Combined With CAV/IE Regimen
- Where
- Guangzhou
- Életkor
- 14 év to 70 év
- People
- 134
- Run by
- Sun Yat-sen University
See details and how to joinNCT04589741 - 2. fázisTaking peoplePreoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma (SPARE-01)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05167994 - No phaseNot yet taking people in KínaNeoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
- Where
- Beijing
- Életkor
- 12 hónap and over
- People
- 55
- Run by
- Peking University People's Hospital
See details and how to joinNCT07620431 - 2. fázisNot yet taking people in KínaPreoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma
- Where
- Beijing
- Életkor
- 15 év and over
- People
- 274
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07612098 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 1/2. fázisTaking peopleThe Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 52
- Run by
- Fudan University
See details and how to joinNCT05774275 - 2. fázisTaking peopleCryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
- Where
- Guangzhou
- Életkor
- 14 év to 70 év
- People
- 57
- Run by
- Sun Yat-sen University
See details and how to joinNCT07602049 - 1. fázisTaking peopleKXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- TCRx Therapeutics Co.Ltd
See details and how to joinNCT07596693 - 2. fázisTaking peopleDoxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
- Where
- Guangzhou
- Életkor
- 6 hónap to 18 év
- People
- 88
- Run by
- Sun Yat-sen University
See details and how to joinNCT05457829 - 1. fázisTaking peoplePhase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Where
- Guangzhou
- Életkor
- 2 év to 18 év
- People
- 51
- Run by
- Sun Yat-sen University
See details and how to joinNCT07584499 - 1. fázisNot yet taking people in KínaA Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07578506 - No phaseTaking peopleSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 26
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552467 - 2. fázisTaking peopleEfficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
- Where
- Hanzhong
- Életkor
- 18 év and over
- People
- 25
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07243626 - 2. fázisTaking peopleClinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangdong, Hangzhou, Harbin, Jinan, Shanghai, Tianjin, Ürümqi, Wuhan, Zhengzhou
- Életkor
- 14 év and over
- People
- 33
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07548177 - No phaseCsak meghívásosOrganoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors
- Where
- Shanghai
- Életkor
- 1 év to 18 év
- People
- 30
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07528079 - 2. fázisTaking peopleEfficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 27
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05926700 - 2. fázisTaking peoplePreoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 22
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07501026 - 1/2. fázisTaking peopleApatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 56
- Run by
- Peking University People's Hospital
See details and how to joinNCT07479732 - 2. fázisNot yet taking people in KínaLiposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS
- Where
- Hangzhou
- Életkor
- 14 év and over
- People
- 24
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07457775 - 3. fázisBefejeződöttPhase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 325 worldwide
- Run by
- Advenchen Laboratories, LLC
See details and how to joinNCT03016819 - 1/2. fázisTaking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - No phaseNot yet taking people in KínaPreoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 28
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07396116